People whose biological mothers had diabetes during pregnancy are more likely to develop multiple sclerosis (MS) as adults, according to a new study from Norway. The study also found that MS risk is heightened among people who were born unusually large, while babies who were abnormally small at birth…
Brenig Therapeutics has launched an early Phase 1 clinical trial to evaluate its experimental small molecule BT-409Â in healthy volunteers. The therapy is being developed for people with multiple sclerosis (MS) and other chronic neurologic conditions. It is aimed at blocking inflammatory responses by targeting the NLRP3 inflammasome,…
Taking oral caffeine supplements may significantly reduce fatigue and improve quality of life and mood in people with multiple sclerosis (MS), according to a recent clinical trial in Iran. Participants took 100 mg of caffeine tablets daily for 12 weeks, equivalent to about two shots of espresso, or a…
Discussion
Every year, January arrives with a familiar script as we are expected to embrace a new year with a clean slate. It’s the season for resolutions and sweeping promises we make to ourselves, as if our bodies have simply been quietly waiting for permission to cooperate. I’m not big on…
A brain protein called anoctamin-2 (ANO2) has emerged as a new piece of the puzzle linking Epstein-Barr virus (EBV) infections to multiple sclerosis (MS), according to a study. Researchers found that immune T-cells from people with MS can mistake ANO2 for an EBV protein, triggering a cross-reactive response…
Get regular updates to your inbox.
